Aggressive Surgical Approach for Treatment of Primary and Recurrent Retroperitoneal Soft Tissue Sarcoma. 2018

Antonio Chiappa, and Emilio Bertani, and Gabriella Pravettoni, and Andrew Paul Zbar, and Diego Foschi, and Giuseppe Spinoglio, and Bernardo Bonanni, and Gianluca Polvani, and Federico Ambrogi, and Maria Laura Cossu, and Carlo Ferrari, and Marco Venturino, and Cristiano Crosta, and Luca Bocciolone, and Roberto Biffi
1Unit of Innovative Surgical Techniques - European Institute of Oncology, University of Milan, via Ripamonti, 435, 20141 Milan, Italy.

To analyze treatment and survival in a series of resected patients with primary or recurrent retroperitoneal sarcoma (RPS) treated and prospectively followed at a single institution. Between July 1994 and December 2015, 89 patients (36 M, 53 F; mean age 60 years, range 25-79) were evaluated. For the purpose of analysis, complete resection was defined as removal of gross tumor with histologically confirmed clear resection margins. Eighty-three out of the 89 patients (93%), 46 of whom affected by primary RPS, and 37 by recurrent RPS, underwent surgical exploration. Sixty-two had a grossly and microscopically complete resection. Fifty-three out of 83 patients (64%) underwent removal of contiguous intra-abdominal organs. Preoperative mortality was nil and significant preoperative complications occurred in six cases only (7%). High-grade tumor pointed out to be a significant variable for a worse survival in all 83 patients amenable to undergo surgical resection (57% 5 years survival for low grade vs 14% for high grade; P = 0.0004). Among completely resected patients, only histologic grade clearly affected disease-free survival (72% 5 years survival for low grade vs 50% for high grade; P = 0.04), while the role of preoperative blood transfusions (67% 5 years survival for non-transfused patients vs 29% for transfused patients; P = 0.05) has to be evaluated in connection to patient complexity. Histological grade and recurrence are the most valuable prognostic predictors; in this clinical subset, an aggressive surgical approach in both primary and recurrent RPS is associated with a best long-term survival and disease-free survival.

UI MeSH Term Description Entries

Related Publications

Antonio Chiappa, and Emilio Bertani, and Gabriella Pravettoni, and Andrew Paul Zbar, and Diego Foschi, and Giuseppe Spinoglio, and Bernardo Bonanni, and Gianluca Polvani, and Federico Ambrogi, and Maria Laura Cossu, and Carlo Ferrari, and Marco Venturino, and Cristiano Crosta, and Luca Bocciolone, and Roberto Biffi
July 1999, World journal of surgery,
Antonio Chiappa, and Emilio Bertani, and Gabriella Pravettoni, and Andrew Paul Zbar, and Diego Foschi, and Giuseppe Spinoglio, and Bernardo Bonanni, and Gianluca Polvani, and Federico Ambrogi, and Maria Laura Cossu, and Carlo Ferrari, and Marco Venturino, and Cristiano Crosta, and Luca Bocciolone, and Roberto Biffi
December 2002, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology,
Antonio Chiappa, and Emilio Bertani, and Gabriella Pravettoni, and Andrew Paul Zbar, and Diego Foschi, and Giuseppe Spinoglio, and Bernardo Bonanni, and Gianluca Polvani, and Federico Ambrogi, and Maria Laura Cossu, and Carlo Ferrari, and Marco Venturino, and Cristiano Crosta, and Luca Bocciolone, and Roberto Biffi
July 2006, International journal of radiation oncology, biology, physics,
Antonio Chiappa, and Emilio Bertani, and Gabriella Pravettoni, and Andrew Paul Zbar, and Diego Foschi, and Giuseppe Spinoglio, and Bernardo Bonanni, and Gianluca Polvani, and Federico Ambrogi, and Maria Laura Cossu, and Carlo Ferrari, and Marco Venturino, and Cristiano Crosta, and Luca Bocciolone, and Roberto Biffi
August 2021, European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology,
Antonio Chiappa, and Emilio Bertani, and Gabriella Pravettoni, and Andrew Paul Zbar, and Diego Foschi, and Giuseppe Spinoglio, and Bernardo Bonanni, and Gianluca Polvani, and Federico Ambrogi, and Maria Laura Cossu, and Carlo Ferrari, and Marco Venturino, and Cristiano Crosta, and Luca Bocciolone, and Roberto Biffi
January 2022, Der Chirurg; Zeitschrift fur alle Gebiete der operativen Medizen,
Antonio Chiappa, and Emilio Bertani, and Gabriella Pravettoni, and Andrew Paul Zbar, and Diego Foschi, and Giuseppe Spinoglio, and Bernardo Bonanni, and Gianluca Polvani, and Federico Ambrogi, and Maria Laura Cossu, and Carlo Ferrari, and Marco Venturino, and Cristiano Crosta, and Luca Bocciolone, and Roberto Biffi
September 2009, European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology,
Antonio Chiappa, and Emilio Bertani, and Gabriella Pravettoni, and Andrew Paul Zbar, and Diego Foschi, and Giuseppe Spinoglio, and Bernardo Bonanni, and Gianluca Polvani, and Federico Ambrogi, and Maria Laura Cossu, and Carlo Ferrari, and Marco Venturino, and Cristiano Crosta, and Luca Bocciolone, and Roberto Biffi
January 2007, International journal of radiation oncology, biology, physics,
Antonio Chiappa, and Emilio Bertani, and Gabriella Pravettoni, and Andrew Paul Zbar, and Diego Foschi, and Giuseppe Spinoglio, and Bernardo Bonanni, and Gianluca Polvani, and Federico Ambrogi, and Maria Laura Cossu, and Carlo Ferrari, and Marco Venturino, and Cristiano Crosta, and Luca Bocciolone, and Roberto Biffi
January 1994, Zhonghua zhong liu za zhi [Chinese journal of oncology],
Antonio Chiappa, and Emilio Bertani, and Gabriella Pravettoni, and Andrew Paul Zbar, and Diego Foschi, and Giuseppe Spinoglio, and Bernardo Bonanni, and Gianluca Polvani, and Federico Ambrogi, and Maria Laura Cossu, and Carlo Ferrari, and Marco Venturino, and Cristiano Crosta, and Luca Bocciolone, and Roberto Biffi
September 2010, World journal of surgical oncology,
Antonio Chiappa, and Emilio Bertani, and Gabriella Pravettoni, and Andrew Paul Zbar, and Diego Foschi, and Giuseppe Spinoglio, and Bernardo Bonanni, and Gianluca Polvani, and Federico Ambrogi, and Maria Laura Cossu, and Carlo Ferrari, and Marco Venturino, and Cristiano Crosta, and Luca Bocciolone, and Roberto Biffi
May 2010, Cancer,
Copied contents to your clipboard!